(99m)Tc-sestamibi SPECT/CT and (18)F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma

(18)F-fluorodeoxiglucose ((18)F-FDG)-PET/CT has been widely used to evaluate multiple myeloma. (99m)Tc-sestamibi (MIBI) scintigraphy has also been proposed for assessing multiple myeloma, but its use with state-of-the-art single-photon emission computed tomography/computed tomography (SPECT/CT) tech...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nucl Med Commun
Main Authors: Mosci, Camila, Pericole, Fernando V., Oliveira, Gislaine B., Delamain, Marcia T., Takahashi, Maria E.S., Carvalheira, José Barreto C., Etchebehere, Elba C.S.C., Santos, Allan O., Miranda, Eliana C. M., Lima, Mariana C.L., Amorim, Barbara J., de Souza, Carmino A., Lorand-Metze, Irene, Ramos, Celso D.
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2020
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497601/
https://ncbi.nlm.nih.gov/pubmed/32732603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNM.0000000000001259
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares